0
The Ondansetron 2 mg | 20 mL Injectable MDV (ACC-16729-0298-05) is a pharmaceutical-grade injectable solution designed for the effective management of nausea and vomiting associated with various medical treatments. This product is an essential tool for healthcare providers in both hospital and outpatient settings, offering a reliable and convenient option for patient care.
Key Features:
- Active Ingredient: Each 20 mL vial contains Ondansetron 2 mg, an antiemetic medication that works by blocking serotonin receptors in the brain, thereby preventing nausea and vomiting. Ondansetron is commonly used to manage symptoms induced by chemotherapy, radiation therapy, and surgery.
- Multi-Dose Vial (MDV): The 20 mL vial is a multi-dose format, allowing for multiple administrations from a single vial, which is ideal for treating multiple patients or providing doses over an extended period. The MDV design ensures efficient use and minimizes waste.
- Convenient Dosage: With 2 mg of Ondansetron per 20 mL, this injectable solution offers flexibility in dosing, allowing healthcare professionals to administer the precise amount needed for effective symptom control.
- Sterile and Safe: The injectable solution is sterile and manufactured under stringent quality controls to ensure safety and efficacy. The product is designed for intravenous (IV) or intramuscular (IM) administration, depending on clinical requirements.
- Rapid Onset of Action: Ondansetron acts quickly to alleviate nausea and vomiting, providing prompt relief for patients undergoing treatments that may induce these symptoms. This rapid onset is crucial for maintaining patient comfort and ensuring adherence to treatment protocols.
